Alkermes plc Reports Second Quarter 2021 Financial Results

Go back to Alkermes plc Reports Second Quarter 2021 Financial Results

Alkermes (ALKS) PT Raised to $25 at Cantor Fitzgerald

July 28, 2021 10:53 AM EDT

Cantor Fitzgerald analyst Brandon Folkes raised the price target on Alkermes (NASDAQ: ALKS) to $25.00 (from $22.00) while maintaining a Neutral rating.

The analyst commented, "Post 2Q21, we reiterate our Neutral rating and revise our 12-month price target to $25, from $22. ALKS has successfully... More

Alkermes (ALKS) PT Raised to $25 at Stifel

July 28, 2021 10:05 AM EDT

Stifel analyst Paul Matteis raised the price target on Alkermes (NASDAQ: ALKS) to $25.00 (from $23.00) while maintaining a Hold rating.

The analyst commented, "We remain Hold rated on ALKS, though we are raising our target price to $25 from $23 after strong sales beats and a... More

UPDATE: Alkermes (ALKS) Tops Q2 EPS by 18c (CORRECTION)

July 28, 2021 7:02 AM EDT

(Updated - July 28, 2021 11:14 AM EDT)

Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.30, $0.18 better than the analyst estimate of $0.12. Revenue for the quarter came in at $303.7 million versus the consensus estimate of $278.7 million.

GUIDANCE:

Alkermes sees FY2021 EPS of $0.52-$0.70,... More